(R,R)/(S,S)-2-phenylhexan-3-ol | 88790-31-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (R,R)/(S,S)-2-phenylhexan-3-ol
• 英文别名: 2-Phenylhexan-3-ol
• CAS: 88790-31-2
• 化学式: C₁₂H₁₈O
• 分子量: 178.274
• InChiKey: AEXSIHXBJLXGNW-UHFFFAOYSA-N

物化性质

• 沸点：
  150-155 °C(Press: 30 Torr)
• 密度：
  0.966 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (R,R)/(S,S)-2-phenylhexan-3-ol 在 chromium(VI) oxide 、 盐酸 、 溶剂黄146 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 2.0h， 生成 4-Methyl-3-propyl-3,4-dihydroisochromen-1-one
  参考文献：
  名称：

  Singh; Singh; Srivastava, Journal of the Indian Chemical Society, 1991, vol. 68, # 5, p. 276 - 280

  摘要：

  DOI：
• 作为产物：
  描述：

  乙基苯 、 正丁醇 以 丙酮 为溶剂， 反应 24.0h， 生成 (R,R)/(S,S)-2-phenylhexan-3-ol
  参考文献：
  名称：

  Pasternak, Mordechai; Morduchowitz, Abraham, Tetrahedron Letters, 1983, vol. 24, # 33, p. 3439 - 3442

  摘要：

  DOI：

文献信息

• 6-Membered heterocyclic compound and use thereof
  申请人：Shoda Motoshi

  公开号：US20070060590A1

  公开（公告）日：2007-03-15

  A compound represented by the general formula (I) or a salt thereof: [T represents oxygen atom and the like; V represents CH 2 and the like; R O1 to R O4 represent hydrogen atom and the like; A represents a linear alkylene group or linear alkenylene group having 2 to 8 carbon atoms and the like; D represents carboxyl group and the like; X represents ethylene group, trimethylene group and the like; E represents —CH(OH)— group and the like; and W represent —U 1 —(R W1 )(R W2 )—U 2 —U 3 group (U 1 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; R W1 and R W2 represent hydrogen atom and the like; U 2 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; and U 3 represent an alkyl group having 1 to 8 carbon atoms and the like), or a residue of a carbon ring or heterocyclic compound], which can be utilized as an active ingredient of medicaments effective for prophylactic and/or therapeutic treatment of skeletal diseases such as osteoporosis and fracture, glaucoma, ulcerative colitis and the like.

  由通用公式(I)表示的化合物或其盐： [T代表氧原子等；V代表CH2等；RO1至RO4代表氢原子等；A代表具有2至8个碳原子的线型亚烷基或线型亚烯基等；D代表羧基等；X代表亚乙基、亚丙基等；E代表—CH(OH)—基团等；W代表—U1—(RW1)(RW2)—U2—U3基团（U1代表单键、具有1至4个碳原子的亚烷基等；RW1和RW2代表氢原子等；U2代表单键、具有1至4个碳原子的亚烷基等；U3代表具有1至8个碳原子的烷基等），或碳环或杂环化合物的残基]，其可作为预防性和/或治疗性药物的有效成分，用于治疗骨骼疾病如骨质疏松症和骨折、青光眼、溃疡性结肠炎等。
• Highly regioselective reaction of zirconocene-alkene complexes with aldehydes or ketones
  作者：Noriyuki Suzuki、Christophe J. Rousset、Koichiro Aoyagi、Martin Kotora、Tamotsu Takahashi、Maki Hasegawa、Yu Nitto、Masahiko Saburi

  DOI：10.1016/0022-328x(94)80112-6

  日期：1994.6

  Reactions of zirconocene-alkene complexes Cp2Zr(CH2CHR)(PR′3) (R  H, Me, Et, SiR″3 or Ar) with aldehydes or ketones were investigated. Zirconocene-ethylene, -propylene or 1-butene complexes reacted with aldehydes or ketones at terminal carbons of alkenes to give the corresponding alcohols after hydrolysis with a high regioselectivity. A similar type of reaction product was also obtained by a reaction

  的锆-烯烃络合物的Cp反应2的Zr（CH 2 CHR）（PR' 3）（RH，ME等，先生“ 3或Ar）与醛或酮的关系进行了研究。锆茂-乙烯，-丙烯或1-丁烯络合物在烯烃的末端碳上与醛或酮反应，在水解后具有高区域选择性，得到相应的醇。氧化锆环戊烷与醛的反应也获得了相似类型的反应产物。该反应通过锆碳环戊烷的β-β'碳-碳键裂解进行。锆茂-乙烯基硅烷络合物与酮的反应得到具有优异区域选择性的3-三甲基甲硅烷基-1-氧杂-2-氧化锆环戊烷。碳-碳键的形成仅发生在乙烯基硅烷的末端碳上。水解后得到它们相应的γ-甲硅烷基醇。产物表明，乙烯基硅烷与β-碳上的羰基化合物反应生成甲硅烷基。它与乙烯基硅烷的常规反应形成鲜明对比，后者的α-碳通常会侵蚀亲电体。苯乙烯及其衍生物与戊烷-3-酮在锆上的反应产生了两种区域异构体的混合物。在1-氧杂-2-氧化锆环戊烷中，烯烃的取代基倾向于位于Zr的α位。该取向显示了由锆
• Zirconium Mediated Regioselective Carbon-Carbon Bond Formation Reactions
  作者：Tamotsu Takahashi、Noriyuki Suzuki、Maki Hasegawa、Yu Nitto、Ko-ichiro Aoyagi、Masahiko Saburi

  DOI：10.1246/cl.1992.331

  日期：1992.2

  Reactions of zirconocene-alkene complexes with aldehydes gave alcohols as coupling products after hydrolysis. The carbon-carbon bond formation proceeded at C1 carbon of alkenes, in sharp contrast to the reactions of alkene-alkene coupling on zirconium. A similar alcohol was also obtained by the reaction of zirconacyclopentane with aldehyde after hydrolysis. Treatment of (C5Me5)2ZrEt2 with styrene gave

  锆茂-烯烃配合物与醛的反应在水解后得到醇作为偶联产物。碳-碳键的形成是在烯烃的 C1 碳上进行的，这与烯烃-烯烃偶联在锆上的反应形成鲜明对比。通过水解后的锆并环戊烷与醛反应也得到类似的醇。(C5Me5)2ZrEt2 用苯乙烯处理水解后得到 2-苯基丁烷，这与 Cp2ZrEt2 得到 1-苯基丁烷的情况相反。
• SIX-MEMBERED HETEROCYCLIC COMPOUND AND THE USE THEREOF
  申请人：Asahi Kasei Pharma Corporation

  公开号：EP1847533A1

  公开（公告）日：2007-10-24

  A compound represented by the general formula (I) or a salt thereof: [T represents oxygen atom and the like; V represents CH2 and the like; RO1 to RO4 represent hydrogen atom and the like; A represents a linear alkylene group or linear alkenylene group having 2 to 8 carbon atoms and the like; D represents carboxyl group and the like; X represents ethylene group, trimethylene group and the like; E represents -CH(OH)- group and the like; and W represent -U1-(RW1)(RW2)-U2-U3 group (U1 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; RW1 and RW2 represent hydrogen atom and the like; U2 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; and U3 represent an alkyl group having 1 to 8 carbon atoms and the like), or a residue of a carbon ring or heterocyclic compound], which can be utilized as an active ingredient of medicaments effective for prophylactic and/or therapeutic treatment of skeletal diseases such as osteoporosis and fracture, glaucoma, ulcerative colitis and the like.

  通式 (I) 所代表的化合物或其盐： [T 代表氧原子等；V 代表 CH2 等；RO1 至 RO4 代表氢原子等；A 代表具有 2 至 8 个碳原子的直链烯基或直链烯基等；D 代表羧基等；X 代表乙烯基、三亚甲基等；E 代表-CH(OH)- 基等；W 代表-U1-(RW1)(RW2)-U2-U3 基（U1 代表单键、具有 1 至 4 个碳原子的亚烷基等）；RW1 和 RW2 代表氢原子等；U2 代表单键、具有 1 至 4 个碳原子的亚烷基等；U3 代表具有 1 至 8 个碳原子的烷基等），或碳环或杂环化合物的残基]，可用作有效预防和/或治疗骨质疏松症和骨折等骨骼疾病、青光眼、溃疡性结肠炎等疾病的药物的活性成分。
• PASTERNAK, M.;MORDUCHOWITZ, A., TETRAHEDRON LETT., 1983, 24, N 33, 3439-3442
  作者：PASTERNAK, M.、MORDUCHOWITZ, A.

  DOI：——

  日期：——